Journal of Clinical Pediatrics >
Comparison of the ratio method drug susceptibility test, micropore-plate method and whole-genome sequencing of anti-tuberculosis drugs in children
Received date: 2022-01-13
Online published: 2023-02-16
Objective To explore the value of drug susceptibility test (DST) by micropore-plate method and whole-genome sequencing (WGS) in detecting the drug resistance of anti-tuberculosis drugs in children. Methods Sixty-one partially preserved strains with positive culture of Mycobacterium tuberculosis (MTB) were collected. The drug resistance of isoniazid, rifampicin, ethambutol, and streptomycin were detected by proportional method, micropore-plate method DST and WGS. The variants of four drug resistance related genes in WGS were summarized, and the clinical data, treatment plan and recovery of the affected children were collected. The reasons for the differences of drug resistance detected by the three methods were analyzed. Results Among 61 MTB strains, 78.69% (n=48) were pan-susceptible strains, 1.64% (n=1) was isoniazid-resistant strain, 1.64% (n=1) was streptomycin resistant strain, 6.56% (n=4) were isoniazid and streptomycin resistant strains, 3.28% (n=2) were isoniazid, rifampicin, and ethambutol resistant strains, 3.28% (n=2) were isoniazid, rifampicin and streptomycin resistant strains, and 4.92% (n=3) were resistant to the four drugs. The sensitivity, specificity, positive predictive value, negative predictive value, and the Kappa value of micropore-plate method for predicting isoniazid resistance were 100%, 92.0%, 73.3%, 100% and 0.81, for rifampicin were 85.7%, 98.2%, 85.7%, 98.2% and 0.84, for ethambutol were 0.0%, 100%, 0.0%, 91.8% and 0.0, for streptomycin were 80.0%, 98.0%, 88.9%, 96.2% and 0.81, respectively. The sensitivity, specificity, positive predictive value, negative predictive value, and the Kappa value of WGS for predicting isoniazid resistance were 90.9%, 94.0%, 76.9%, 97.9% and 0.79, for rifampicin were 100%, 98.2%, 87.5%, 100% and 0.92, for ethambutol were 60.0%, 94.6%, 50.0%, 96.4% and 0.50, for streptomycin were 80.0%, 98.0%, 88.9%, 96.2% and 0.81, respectively. Conclusion Highly consistent with ratio method, micropore-plate method and WGS have higher sensitivity to predict isoniazid, rifampin, and streptomycin resistant tuberculosis in children, which can replace traditional proportional method in clinical practice. However, it is suggested to use proportional method combined with WGS to comprehensively evaluate the ethambutol resistance of MTB, as the consistency of micropore-plate and ratio methods is poor.
Ying ZHANG , Qiaoli REN , Ruiqiu ZHAO , Hongmei XU , Xiaoru LONG . Comparison of the ratio method drug susceptibility test, micropore-plate method and whole-genome sequencing of anti-tuberculosis drugs in children[J]. Journal of Clinical Pediatrics, 2023 , 41(2) : 117 -124 . DOI: 10.12372/jcp.2023.22e0083
[1] | 刘珍敏, 赵瑞秋, 许红梅. 结核感染T细胞斑点试验、涂片检查和结核菌素试验在儿童结核病诊断中的价值[J]. 临床儿科杂志, 2019, 37(4): 282-287. |
[2] | World Health Organization. Global tuberculosis report 2021[M]. Geneva: World Health Organization, 2021. |
[3] | Yang R, Liu M, Jiang H, et al. The epidemiology of pulmonary tuberculosis in children in Mainland China, 2009-2015 [J]. Arch Dis Child, 2020, 105(4): 319-325. |
[4] | 杨丽燕, 黄延风, 余雅, 等. 920例儿童肺结核临床流行病学特征分析[J]. 临床儿科杂志, 2019, 37(6): 413-417. |
[5] | Jenkins HE, Yuen CM. The burden of multidrug-resistant tuberculosis in children[J]. Int J Tuberc Lung Dis, 2018, 22(5): 3-6. |
[6] | World Health Organization. Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions, 17-19 November 2020[M]. Geneva: World Health Organization, 2021. |
[7] | 中国防痨协会基础专业委员会. 结核病诊断实验室检验规程[M]. 北京: 中国教育文化出版社, 2006. |
[8] | Meehan CJ, Goig GA, Kohl TA, et al. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues[J]. Nat Rev Microbiol, 2019, 17(9): 533-545. |
[9] | Papaventsis D, Casali N, Kontsevaya I, et al. Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review[J]. Clin Microbiol Infect, 2017, 23(2): 61-68.. |
[10] | Anwaierjiang A, Wang Q, Liu H, et al. Prevalence and molecular characteristics based on whole genome sequencing of Mycobacterium tuberculosis resistant to four anti-tuberculosis drugs from Southern Xinjiang, China[J]. Infect Drug Resist, 2021, 14: 3379-3391. |
[11] | 王云霞. 微孔板法检测结核分枝杆菌对利福平的药物敏感性分析[J]. 现代诊断与治疗, 2020, 31(6): 845-847. |
[12] | 杨翰, 杨静芬, 伍浩, 等. 微孔板法在一线抗结核药物敏感性试验中的应用价值[J]. 中国防痨杂志, 2020, 42(4): 380-384. |
[13] | Manson AL, Cohen KA, Abeel T, et al. Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance[J]. Nat Genet, 2017, 49(3): 395-402. |
[14] | Huo F, Lu J, Zong Z, et al. Change in prevalence and molecular characteristics of isoniazid-resistant tuberculosis over a 10-year period in China[J]. BMC Infect Dis, 2019, 19(1): 689. |
[15] | Song WM, Li YF, Ma XB, et al. Primary drug resistance of Mycobacterium tuberculosis in Shandong, China, 2004-2018 [J]. Respir Res, 2019, 20(1): 223. |
[16] | Park J, Shin SY, Kim K, et al. Determining genotypic drug resistance by ion semiconductor sequencing with the ion ampliSeq? TB panel in multidrug-resistant Mycobacterium tuberculosis Isolates[J]. Ann Lab Med, 2018, 38(4): 316-323. |
[17] | Malenfant JH, Brewer TF. Rifampicin mono-resistant tuberculosis-a review of an uncommon but growing challenge for global tuberculosis control[J]. Open Forum Infect Dis, 2021, 8(2): ofab018. |
[18] | Nonghanphithak D, Kaewprasert O, Chaiyachat P, et al. Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB[J]. PLoS One, 2020, 15(12): e0244829. |
[19] | WHO Guidelines Approved by the Guidelines Review Committee. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis[M]. Geneva: World Health Organization, 2014. |
[20] | Zhao LL, Sun Q, Liu HC, et al. Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates from China[J]. Antimicrobi agents chemother, 2015, 59(4): 2045-2050. |
[21] | Baku?a Z, Napiórkowska A, Bielecki J, et al. Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland[J]. Biomed Res Int, 2013, 2013: 167954. |
[22] | Tulyaprawat O, Chaiprasert A, Chongtrakool P, et al. Distribution of embB mutations of Thai clinical isolates of ethambutol-resistant Mycobacterium tuberculosis[J]. J Glob Antimicrob Resist, 2019, 18: 115-117. |
[23] | He G, Li Y, Chen X, et al. Prediction of treatment outcomes for multidrug-resistant tuberculosis by whole-genome sequencing[J]. Int J Infect Dis, 2020, 96: 68-72. |
/
〈 |
|
〉 |